Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from RTTNews

23:24 EDT 24th September 2018 | BioPortfolio

Here are the most relevant search results for "RTTNews" found in our extensive news archives from over 250 global news sources.

More Information about RTTNews on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about RTTNews for you to read. Along with our medical data and news we also list RTTNews Clinical Trials, which are updated daily. BioPortfolio also has a large database of RTTNews Companies for you to search.

Showing News Articles 1–25 of 429 from RTTNews

Monday 24th September 2018

AMRN Heartens Investors, AKCA On Watch, ACRX Faces FDA Panel In Oct.

The following are some of today's top gainers in the pharma/biotech sector.

Saturday 22nd September 2018

Week Ahead In Pharmaceuticals: 10 Stocks To Watch (CKPT, SNDX, ADMP...)

Clinical trial data is an important catalyst, and any update on the clinical studies can send the biotech/pharma stocks soaring or stumbling depending upon the news. Now, here are some of the pharma/biotech stocks to watch out for in the week starting September 24.

Thursday 20th September 2018

Hot TLRY Cooling Off, ITRM On Watch, OMED To Report Phase Ib Data In Oct.

The following are some of the pharma/biotech stocks that posted the biggest percentage decline today.

ALT Up 514% In 2 Days, CRBP Well Stocked, ACAD Soars On FDA Review

The following are some of today's top gainers in the pharma/biotech sector.

D-Day Nearing For Antares Pharma

Shares of Antares Pharma Inc. (ATRS) have lost nearly 7% of their value so far this month, as the company's regulatory catalyst draws closer. Antares Pharma is a revenue-generating, specialty pharmaceutical company, focusing on self-injection pharmaceutical products and technologies, and topical gel-based products.

Wednesday 19th September 2018

UBX To Report Phase I Data In Q1, NVTA On Watch, NTGN Faces Busy Year Ahead

The following are some of the pharma/biotech stocks that posted the biggest percentage decline today.

MTEM Abuzz, TLRY Up 1,240% In 2 Months, ALT Awaits Anthrax Data In Q4

The following are some of today's top gainers in the pharma/biotech sector.

Sunday 16th September 2018

Botox Effect Lasts Longer At Higher Doses, TEVA Gets FDA Nod, KNSA On Watch

Today's Daily Dose brings you news about results from Allergan's clinical study evaluating higher doses of BOTOX Cosmetic; CEL-SCI's better capitalization, following exercise of warrants; Kiniksa's phase 1a/1b clinical trial of KPL-716 in moderate-to-severe atopic dermatitis, and FDA approval of Teva's preventive treatment of migraine.

Friday 14th September 2018

Week Ahead In Pharmaceuticals: 7 Stocks To Watch (CMRX, VRNA, NITE...)

As another week comes to a close, it is time to take a look back at some of the pharma news that made headlines and look ahead at what's coming next over the horizon.

Thursday 13th September 2018

CGC Cooling Off, PGNX Slumps As Phase 3 Trial Flops, PLXP On Watch

The following are some of the pharma/biotech stocks that posted the biggest percentage decline today.

NMRD Up 60% In 2 Days, TLRY Keeps Hitting New Highs, MNLO Awaits Data In Oct.

The following are some of today's top gainers in the pharma/biotech sector.

ADIL On Track, PGNX Slumps On Phase III Study Failure, VNDA On Watch

Today's Daily Dose brings you news about disappointing results of Progenics Pharma's 1404, an imaging compound targeting prostate specific membrane antigen,trial; stock offerings of Galapagos and Xenon Pharma and Hetlioz's edge over Zopiclone in driving impairment.

Wednesday 12th September 2018

VTL To Dump ELAD System, KRYS Awaits Data Readout In Q4, COOL On Watch

The following are some of the pharma/biotech stocks that posted the biggest percentage decline today.

NMRD Turning Heads, EVFM Awaits Contraceptive Gel Data, SLDB Making Solid Gains

The following are some of today's top gainers in the pharma/biotech sector.

What Awaits Arena Pharma This Month?

Shares of Arena Pharmaceuticals Inc. (ARNA) have returned 18% year-to-date, nearly double the gain of the Nasdaq Biotechnology index.

FOMX Soars On Acne Trial Data, GLPG Abuzz, ACRX To Face FDA Panel In Oct.

Today's Daily Dose brings you news about AcelRx Pharma's regulatory catalyst in October; positive acne trial results of Foamix; Galapagos' rheumatoid arthritis trial results; trading halt in OPKO and Viveve Medical's progress in stress urinary incontinence studies.

Tuesday 11th September 2018

XBIT Slumps To New Low, EVFM On Track, EKSO On Watch

The following are some of the pharma/biotech stocks that posted the biggest percentage decline today.

TLRY Sizzling Hot, IVTY To Be Bought Out, PRQR Up 172% In 6 Days

The following are some of today's top gainers in the pharma/biotech sector.

Cerner's Zane Burke Steps Down As President

Zane Burke, president of Cerner Corp. (CERN) is stepping down on November 2. The company cited no reason for his departure.

FPRX Advances FIGHT, SIGA Secures BARDA Contract, TRVN Faces FDA Panel In Oct.

Today's Daily Dose brings you news about Applied Genetic's near-term catalyst; Centric Health's new contract; SIGA's $629 million, multi-year contract with BARDA; the FDA panel review date of Trevena's Oliceridine injection, and Xenon's agreement with Bausch Health related to epilepsy drug candidate.

Monday 10th September 2018

ACOR Loses Ampyra Patent Appeal, XBIT Awaits Data, AYTU Touches New Low

The following are some of the pharma/biotech stocks that posted the biggest percentage decline today.

Delcath Gets Focus, PRQR Keeps Hitting New Highs, ECYT Turning Heads

The following are some of today's top gainers in the pharma/biotech sector.

Saturday 8th September 2018

Week Ahead In Pharmaceuticals: 5 Stocks To Watch (KNSA, INCY, ANAB...)

A lot happened in the pharma sector in the week, with some bringing joy to investors while some caused heartbreaks. Here are some of the pharma/biotech stocks to watch out for in the week starting September 10.

Thursday 6th September 2018

IOVA Slumps, MSON On Watch, ALRN To Report Data In Q4

The following are some of the pharma/biotech stocks that posted the biggest percentage decline today.

GEMP Jumps Over 40%, EVFM Awaits Pivotal Contraceptive Gel Data, ARWR Abuzz

The following are some of today's top gainers in the pharma/biotech sector.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks